Compare CXDO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXDO | ORMP |
|---|---|---|
| Founded | 1995 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 170.3M |
| IPO Year | 1999 | 2010 |
| Metric | CXDO | ORMP |
|---|---|---|
| Price | $5.93 | $4.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.20 | N/A |
| AVG Volume (30 Days) | ★ 257.0K | 194.0K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 166.67 | ★ 412.50 |
| EPS | 0.05 | ★ 2.76 |
| Revenue | ★ $68,167,000.00 | $2,000,000.00 |
| Revenue This Year | $45.26 | N/A |
| Revenue Next Year | $13.31 | N/A |
| P/E Ratio | $115.80 | ★ $1.70 |
| Revenue Growth | 12.05 | ★ 49.25 |
| 52 Week Low | $5.54 | $2.09 |
| 52 Week High | $11.23 | $5.47 |
| Indicator | CXDO | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 49.71 |
| Support Level | N/A | $3.91 |
| Resistance Level | N/A | $5.01 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 27.87 |
Crexendo Inc is a software technology company that provides cloud communication platform software and unified communications as a service (UCaaS) offering, including voice, video, contact center, and managed IT services. The company operates through two segments: Cloud Telecommunications Services and Software Solutions. Its cloud telecommunications segment generates revenue from the provision of broadband Internet services, managed IT services, software license sales, and infrastructure as a service. The software solutions segment derives revenues from three primary sources: software licenses, software maintenance support and professional services. The majority of the company's revenue is derived from the Cloud Telecommunications Services segment.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.